» Articles » PMID: 39858402

Discovery and Characterization of Two Selective Inhibitors for a Mu-Class Glutathione S-Transferase of 25 KDa from Using Computational and Bioinformatics Tools

Overview
Journal Biomolecules
Publisher MDPI
Date 2025 Jan 25
PMID 39858402
Authors
Affiliations
Soon will be listed here.
Abstract

Glutathione S-transferases (GSTs) are promising pharmacological targets for developing antiparasitic agents against helminths, as they play a key role in detoxifying cytotoxic xenobiotics and managing oxidative stress. Inhibiting GST activity can compromise parasite viability. This study reports the successful identification of two selective inhibitors for the mu-class glutathione S-transferase of 25 kDa (Ts25GST) from , named and , using a computationally guided approach. The workflow involved modeling and refining the 3D structure from the sequence using the AlphaFold algorithm and all-atom molecular dynamics simulations with an explicit solvent. Representative structures from these simulations and a putative binding site with low conservation relative to human GSTs, identified via the SILCS methodology, were employed for virtual screening through ensemble docking against a commercial compound library. The two compounds were found to reduce the enzyme's activity by 50-70% under assay conditions, while showing a reduction of only 30-35% for human mu-class GSTM1, demonstrating selectivity for Ts25GST. Notable, displayed competitive inhibition with CDNB, while exhibited a non-competitive inhibition type.

References
1.
Jones G, Willett P, Glen R . Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. J Mol Biol. 1995; 245(1):43-53. DOI: 10.1016/s0022-2836(95)80037-9. View

2.
Jones G, Willett P, Glen R, Leach A, Taylor R . Development and validation of a genetic algorithm for flexible docking. J Mol Biol. 1997; 267(3):727-48. DOI: 10.1006/jmbi.1996.0897. View

3.
Hofmeyr J, Cornish-Bowden A . The reversible Hill equation: how to incorporate cooperative enzymes into metabolic models. Comput Appl Biosci. 1997; 13(4):377-85. DOI: 10.1093/bioinformatics/13.4.377. View

4.
Paul S, Mytelka D, Dunwiddie C, Persinger C, Munos B, Lindborg S . How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nat Rev Drug Discov. 2010; 9(3):203-14. DOI: 10.1038/nrd3078. View

5.
Hill C, Waight R, Bardsley W . Dose any enzyme follow the Michaelis-Menten equation?. Mol Cell Biochem. 1977; 15(3):173-8. DOI: 10.1007/BF01734107. View